Cormedix Inc (STU:19KA)
€ 9.65 0.25 (2.66%) Market Cap: 601.04 Mil Enterprise Value: 558.66 Mil PE Ratio: 0 PB Ratio: 10.17 GF Score: 52/100

Q4 2021 CorMedix Inc Earnings Call Transcript

Mar 29, 2022 / 08:30PM GMT
Release Date Price: €5 (-8.26%)
Operator

Good afternoon, and welcome to the CorMedix Fourth Quarter Earnings Conference Call.

Today's call is being recorded. There will be a question-and-answer session at the end of today's presentation, and instructions on how to ask a question will be given at that time.

I would now like to turn the conference over to Daniel Ferry from LifeSci Advisors. Please go ahead.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Good afternoon, and welcome to the CorMedix Fourth Quarter and Year-end 2021 Earnings Conference Call. Leading the call today is Dr. Matt David, Interim Chief Executive Officer and Executive Vice President and Chief Financial Officer of CorMedix. He is joined by Dr. Phoebe Mounts, Executive Vice President and General Counsel.

Before we begin, I would like to remind everyone that during the call, management may make what are known as forward-looking statements within the meaning set forth in the Private Securities Litigation Reform Act of 1995. These statements are subject to certain risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot